Omeprazol Vitória (Omeprazole)

Omeprazol Vitória is a proton pump inhibitor that acts on the acid‑secretion pathway in the gastrointestinal tract.

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

• Omeprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to sustained reduction of gastric acidity throughout the dosing interval.

Adverse reactions to omeprazole are generally mild and dose‑dependent.

Common Side Effects

• Headache: mild and transient.
• Diarrhea: watery stools without blood.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild cramping.
• Flatulence: increased gas production.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Acute interstitial nephritis: kidney inflammation with reduced urine output.
• Stevens‑Johnson syndrome: severe skin rash and mucosal involvement.
• Hypersensitivity reactions: rash, itching, or anaphylaxis.
• Osteoporotic fractures: increased risk with long‑term use.
• Vitamin B12 deficiency: anemia‑type symptoms with prolonged therapy.

When using Omeprazol Vitória, consider the following safety measures:

• Assess renal function: adjust use in patients with severe impairment.
• Evaluate hepatic status: use cautiously in moderate liver disease.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Monitor long‑term therapy: assess need for calcium, magnesium and vitamin B12 supplementation.
• Pregnancy and lactation: weigh benefits against potential risks; use only if clearly indicated.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring clinical attention.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir and other protease inhibitors: markedly decreased antiviral efficacy.
• Methotrexate (high dose): increased serum levels and toxicity risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, requiring more frequent monitoring.
• Phenytoin: reduced plasma concentration, possibly diminishing seizure control.
• Diazepam: increased sedation, necessitating dose adjustment.